CORONARY ANGIOGENESIS: DIPYRIDAMOLE IS BACK ON THE STAGE
Abstract
European Heart Journal (2001) 22, 1151-1153.
References
1. Bombardini T, Picano E. The coronary angiogenetic effect of heparin: experimental basis and clinical evidence. Angiology 1997; 48: 969-76
2. Eckstein RW. Effects of exercise and coronary artery narrowing on coronary collateral circulation. Circ Res 1957; 5: 230-5
3. Symons JD, Firoosmand E, Longhurst JC. Repeated dipyridamole administration enhances collateral-dependent flow and regional function during exercise. A role for adenosine. Circ Res 1993; 73: 503-13
4. Picano E, Michelassi C. Chronic oral dipyridamole as a ‘novel’ antianginal drug: the collateral hypothesis. Cardiovasc Res 1997; 33: 666-70
5. Sacks HS, Ancona-Berk VA, Berrier J, Nagalingam R, Chalmers TC. Dipyridamole in the treatment of angina pectoris: a meta-analysis. Clin Pharmacol Ther 1998; 43: 610-15
6. Tornling G, Unge G, Skoog L, Ljungqvist A, Carlsson S, Adolfsson J. Proliferative activity of myocardial capillary wall cells in dipiridamol-treated rats. Cardiovasc Res 1978; 12: 692-5
7. Tornling G, Unge G, Adolfsson J, Ljungqvist A, Carlsson S. Proliferative activity of capillary wall cells in skeletal muscles in rats during long-term treatment with dipyridamole. Arzneimittelforschung 1980; 30: 622-3
8. Torry RJ, O’Brien DM, Connel PM, Tomanek RJ. Dipyridamole-induced capillary growth in normal and hypertrophic hearts. Am J Physiol 1992; 262: H980-H986
9. Belardinelli R, Belardinelli L, Shryok JC. Effects of dipyridamole on coronary collateralization and myocardial perfusion in patients with ischaemic cardiomyopathy. Eur Heart J 2001; 22: 1205-13
10. Khouri EM, Gregg DE, McGranahan GM. Regression and reappearance of coronary collaterals. Am J Physiol 1971; 220: 655-61
Review
For citations:
Lombardi F., Rambaldi R. CORONARY ANGIOGENESIS: DIPYRIDAMOLE IS BACK ON THE STAGE. Russian Journal of Cardiology. 2001;(4):114-115. (In Russ.)
Views:
316
Email this article 